Adjuvant Capital is a venture capital firm that prefers to invest in businesses in the life science sector. Founded in 2012 by Charlie Petty, Glenn Rockman, and Kabeer Aziz in New York, New York. The firm invests in Early Stage Venture. The notable investment portfolio of the Adjuvant Capital includes AN2 Therapeutics, Themis, InDevR, and X-Vax.
As of December 2019, Sony Innovation Fund has made 4 investments and actively looking for new investment opportunities. Adjuvant Capital typically invests around $10-$25 million.
Timeline
Funded Companies
A biotechnology company developing live attenuated vaccines. It was founded in 2012 and is located in New York.
A biotechnology company developing immune-modulation therapies for infectious diseases and cancer leveraging its technology platform and understanding of immune system mechanisms. It was founded in 2009 and is located in Vienna, Austria.
ChromaCode is a Carlsbad, California-based company developing molecular diagnostics and bioinformatics systems.
Boulder-based biotech company specializing in microarray technology and applications
Frontier Nutrition develops and manufactures packages food products, based on research in pediatric nutrition and focused on fighting malnutrition.
54Gene is healthcare startup company providing a genetics testing platform in Africa. It also offers genetic reports on health, nutrition, fitness and weight loss, carrier status, personal traits and ancestry.
MinervaX is an Hellerup-based company founded in 2010 by Per Fischer.
People
Charlie Petty
Principal
Christian Mandl
SENIOR ADVISOR / BOSTON
Curt LaBelle
VENTURE PARTNER / NEW YORK
Evelyn Yanatos
FINANCE DIRECTOR / NEW YORK
Gerard Cunningham
OPERATING PARTNER
Glenn Rockman
FOUNDER / MANAGING PARTNER / NEW YORK
Jenny Yip
MANAGING PARTNER / SAN FRANCISCO
Jim Robinson
SENIOR ADVISOR
Kabeer Aziz
PRINCIPAL / NEW YORK
Kim Kamdar
PARTNER / SAN DIEGO
Lilly deSouza Burr
ASSOCIATE / NEW YORK
Mark Sullivan
VENTURE PARTNER
Michael Chang
PRINCIPAL / NEW YORK
Peter Patriarca
SENIOR ADVISOR / DC
Further reading
Documentaries, videos and podcasts
Companies
AN2 Therapeutics
InDevR
Themis Bioscience
X-Vax Technology
News
References
Company attributes
Venture Capital Firm attributes
Categories
Related Topics
Contributors
- 1
Marie Gabrielle Laguna- Bedia
Co-founder and Managing Partner of Eternus Global. Physician of internal medicine, app developer and entrepreneur - 2
Jed Christiansen
Special Projects & Business Development at Golden, Founder - Seed-DB. - 3
Reys Phillips
A graduate of Cleveland State University with a Bachelor of Science in Education. My main hobbies include story writing and reading. - 4
Aime Anne Nisay
QA Engineer of web and mobile applications - 5
Carla Faraguna
Golden People and Operations. - 6
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME